Omega-3 consumption and sudden cardiac death in schizophrenia

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 81, Issue 4, 2009, Pages 241-245

  Scorza, Fulvio A ^a   Cysneiros, Roberta M ^b   Terra, Vera C ^c   Scorza, Carla A ^a   Cavalheiro, Esper A ^a   Ribeiro, Miriam O ^b   Gattaz, Wagner F ^c  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b MACKENZIE PRESBYTERIAN UNIVERSITY   (Brazil)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Fish.; Heart; Omega 3; Schizophrenia; Sudden cardiac death

Indexed keywords

CLOZAPINE; DOCOSAHEXAENOIC ACID; FISH OIL; ICOSAPENTAENOIC ACID; NEUROLEPTIC AGENT; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; PLACEBO; SOYBEAN OIL; VEGETABLE OIL;

ANTIARRHYTHMIC ACTIVITY; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR PARAMETERS; CARDIOVASCULAR RISK; CLINICAL TRIAL; COMORBIDITY; DIET SUPPLEMENTATION; DIETARY INTAKE; DRUG MECHANISM; FAT INTAKE; FISH; FOOD COMPOSITION; FOOD CONTAMINATION; FOOD SAFETY; HEART ARRHYTHMIA; HEART PROTECTION; HIGH RISK PATIENT; HUMAN; MORTALITY; NONHUMAN; NUTRITIONAL REQUIREMENT; PRIORITY JOURNAL; QT PROLONGATION; RISK BENEFIT ANALYSIS; RISK MANAGEMENT; SCHIZOPHRENIA; SEA FOOD; SUDDEN DEATH;

ANIMALS; DEATH, SUDDEN, CARDIAC; DIETARY SUPPLEMENTS; FATTY ACIDS, OMEGA-3; HUMANS; SCHIZOPHRENIA;

ANIMALIA;

EID: 70349632228     PISSN: 09523278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.plefa.2009.06.008     Document Type: Article

References (66)

1. National Institute of Mental Health. The numbers count: mental disorders in America, Available from: 〈http://www.nimh.nih.gov/publicat/numbers.cfm〉. 2006.
2. Bobes J., Arango C., Aranda P., Carmena R., Garcia-Garcia M., Rejas, and On behalf of the CLAMORS Study Collaborative Group. Cardiovascular and metabolic risk in outpatients with schizophrenia treated with antipsychotics: results of the CLAMORS study. Schizophr. Res. 90 (2007) 162-173
3. Auquier P., Lancon C., Rouillon F., Lader M., and Holmes C. Mortality in schizophrenia. Pharmacoepidemiol. Drug Saf. 15 (2006) 873-879
4. Ruschena D., Mullen P.E., Burgess P., Cordner S.M., Barry-Walsh J., Drummer O.H., et al. Sudden death in psychiatric patients. Br. J. Psychiatry 172 (1998) 331-336
5. Scorza F.A., Mari J.J., and Bressan R.A. Sudden cardiac death in schizophrenia: should the psychiatrist pay more attention?. Rev. Bras. Psiquiatr. 28 (2006) 339
6. Glassman A.H. Schizophrenia, antipsychotic drugs, and cardiovascular disease. J. Clin. Psychiatry 66 (2005) 5-10
7. Straus S.M., Bleumink G.S., Dieleman J.P., van der Lei J., Jong G.W., Kingma J.H., Sturkenboom M.C., and Stricker B.H. Antipsychotics and the risk of sudden cardiac death. Arch. Intern. Med. 164 (2004) 1293-1297
8. Zarate C.A., and Patel J. Sudden cardiac death and antipsychotic drugs: do we know enough?. Arch. Gen. Psychiatry 58 (2001) 1168-1171
9. Ohara K. The n-3 polyunsaturated fatty acid/dopamine hypothesis of schizophrenia. Prog. Neuropsychopharmacol. Biol. Psychiatry 31 2 (2007) 469-474
10. Calon F., and Cole G. Neuroprotective action of omega-3 polyunsaturated fatty acids against neurodegenerative diseases: evidence from animal studies. Prostaglandins Leukot. Essent. Fatty Acids 77 (2007) 287-293
11. Julien C., Berthiaume L., Hadj-Tahar A., Rajput A.H., Bédard P.J., Di Paolo T., Julien P., and Calon F. Postmortem brain fatty acid profile of levodopa-treated Parkinson disease patients and parkinsonian monkeys. Neurochem. Int. 48 (2006) 404-414
12. Mazza M., Pomponi M., Janiri L., Bria P., and Mazza S. Omega-3 fatty acids and antioxidants in neurological and psychiatric diseases: an overview. Prog. Neuropsychopharmacol. Biol. Psychiatry 31 (2007) 12-26
13. Dyerberg J., and Bang H.O. Haemostatic function and platelet polyunsaturated fatty acids in Eskimos. Lancet 2 (1979) 433-435
14. Gudbjarnason S., and Hallgrimsson J. Prostaglandins and polyunsaturated fatty acids in heart muscle. Acta Biol. Med. Ger. 35 (1976) 1069-1080
15. McLennan P.L., Bridle T.M., Abeywardena M.Y., and Charnock J.S. Dietary lipid modulation of ventricular fibrillation threshold in the marmoset monkey. Am. Heart J. 123 (1992) 1555-1561
16. McLennan P.L. Relative effects of dietary saturated, monounsaturated, and polyunsaturated fatty acids on cardiac arrhythmias in rats. Am. J. Clin. Nutr. 57 (1993) 207-212
17. Yang B.C., Saldeen T.G., Bryant J.L., Nichols W.W., and Mehta J.L. Long-term dietary fish oil supplementation protects against ischemia-reperfusion-induced myocardial dysfunction in isolated rat hearts. Am. Heart J. 126 (1993) 1287-1292
18. Jacobsen A.N., Du X.J., Dart A.M., and Woodcock E.A. Ins(1,4,5)P3 and arrhythmogenic responses during myocardial reperfusion: evidence for receptor specificity. Am. J. Physiol. 273 (1997) H1119-H1125
19. Billman G.E., Hallaq H., and Leaf A. Prevention of ischemia-induced ventricular fibrillation by omega 3 fatty acids. Proc. Natl. Acad. Sci. USA 91 (1994) 4427-4430
20. Billman G.E., Kang J.X., and Leaf A. Prevention of ischemia-induced cardiac sudden death by n-3 polyunsaturated fatty acids in dogs. Lipids 32 (1997) 1161-1168
21. Kang J.X., and Leaf A. Effects of long-chain polyunsaturated fatty acids on the contraction of neonatal rat cardiac myocytes. Proc. Natl. Acad. Sci. USA 91 (1994) 9886-9890
22. Kang J.X., and Leaf A. Antiarrhythmic effects of polyunsaturated fatty acids. Recent studies. Circulation 94 (1996) 1774-1780
23. + channels of neonatal rat ventricular myocytes. Proc. Natl. Acad. Sci. USA 92 (1995) 11000-11004
24. 2+ currents by polyunsaturated fatty acids in adult and neonatal rat ventricular myocytes. Proc. Natl. Acad. Sci. USA 94 (1997) 4182-4187
25. Xiao Y.F., Wright S.N., Wang G.K., Morgan J.P., and Leaf A. Coexpression with beta(1)-subunit modifies the kinetics and fatty acid block of hH1(alpha) Na(+) channels. Am. J. Physiol. Heart Circ. Physiol. 279 (2000) H35-H46
26. Leaf A., Kang J.X., Xiao Y.F., and Billman G.E. Clinical prevention of sudden cardiac death by n-3 polyunsaturated fatty acids and mechanism of prevention of arrhythmias by n-3 fish oils. Circulation 107 (2003) 2646-2652
27. Albert C.M., Hennekens C.H., O'Donnell C.J., Ajani U.A., Carey V.J., Willett W.C., Ruskin J.N., and Manson J.E. Fish consumption and risk of sudden cardiac death. JAMA 279 (1998) 23-28
28. Siscovick D.S., Lemaitre R.N., and Mozaffarian D. The fish story: a diet-heart hypothesis with clinical implications: n-3 polyunsaturated fatty acids, myocardial vulnerability, and sudden death. Circulation 107 (2003) 2632-2634
29. Marchioli R. Results of GISSI Prevenzione: diet, drugs, and cardiovascular risk. Researchers of GISSI Prevenzione. Cardiologia 44 (1999) 745-746
30. Marchioli R., Barzi F., Bomba E., Chieffo C., Di Gregorio D., Di Mascio R., Franzosi M.G., Geraci E., Levantesi G., Maggioni A.P., Mantini L., Marfisi R.M., Mastrogiuseppe G., Mininni N., Nicolosi G.L., Santini M., Schweiger C., Tavazzi L., Tognoni G., Tucci C., Valagussa, and GISSI-Prevenzione Investigators. Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI)-Prevenzione. Circulation 105 (2002) 1897-1903
31. Ohara K. Schizophrenia in essential fatty acid. Clin. Psychiatry 34 (2005) 1427-1433
32. Freeman M.P., Hibbeln J.R., Wisner K.L., Davis J.M., Mischoulon D., Peet M., Keck Jr. P.E., Marangell L.B., Richardson A.J., Lake J., and Stoll A.L. Omega-3 fatty acids: evidence basis for treatment and future research in psychiatry. J. Clin. Psychiatry 67 (2006) 1954-1967
33. Peet M., Horrobin D.F., E-E Multicentre Study Group, and Multicentre Study Group. A dose-ranging exploratory study of the effects of ethyl-eicosapentaenoate in patients with persistent schizophrenic symptoms. J. Psychiatr. Res. 36 (2002) 7-18
34. Raitt M.H., Connor W.E., Morris C., Kron J., Halperin B., Chugh S.S., McClelland J., Cook J., MacMurdy K., Swenson R., Connor S.L., Gerhard G., Kraemer D.F., Oseran D., Marchant C., Calhoun D., Shnider R., and McAnulty J. Fish oil supplementation and risk of ventricular tachycardia and ventricular fibrillation in patients with implantable defibrillators: a randomized controlled trial. JAMA 293 (2005) 2884-2891
35. Din J.N., Harding S.A., Valerio C.J., Sarma J., Lyall K., Riemersma R.A., Newby D.E., and Flapan A.D. Dietary intervention with oil rich fish reduces platelet-monocyte aggregation in man. Atherosclerosis 197 (2008) 290-296
36. Harris W.S., and von Schacky C. The omega-3 index: a new risk factor for death from coronary heart disease?. Prev. Med. 39 (2004) 212-220
37. Yao J.K., van Kammen D.P., and Welker J.A. Red blood cell membrane dynamics in schizophrenia. II. Fatty acid composition. Schizophr. Res. 13 (1994) 217-226
38. Yao J.K., van Kammen D.P., and Gurklis J. Red blood cell membrane dynamics in schizophrenia. III. Correlation of fatty acid abnormalities with clinical measures. Schizophr. Res. 13 (1994) 227-232
39. Khan M.M., Evans D.R., Gunna V., Scheffer R.E., Parikh V.V., and Mahadik S.P. Reduced erythrocyte membrane essential fatty acids and increased lipid peroxidesin schizophrenia at the never-medicated first-episode of psychosis and after years of treatment with antipsychotics. Schizophr. Res. 58 (2002) 1-10
40. Yao J.K., Magan S., Sonel A.F., Gurklis J.A., Sanders R., and Reddy R.D. Effects of omega-3 fatty acid on platelet serotonin responsivity in patients with schizophrenia. Prostaglandins Leukot. Essent. Fatty Acids 71 3 (2004) 171-176
41. von Schacky C. Omega-3 fatty acids and cardiovascular disease. Curr. Opin. Clin. Nutr. Metab. Care 10 (2007) 129-135
42. Ismail H.M. The role of omega-3 fatty acids in cardiac protection: an overview. Front. Biosci. 10 (2005) 1079-1088
43. Harris W.S. n-3 fatty acids and serum lipoproteins: human studies. Am. J. Clin. Nutr. 65 (1997) 1645S-1654S
44. Singh R.B., Pella D., Mechirova V., and Otsuka K. Can brain dysfunction be a predisposing factor for metabolic syndrome?. Biomed. Pharmacother. 58 (2004) S56-S68
45. Colugnati D.B., Gomes P.A., Arida R.M., de Albuquerque M., Cysneiros R.M., Cavalheiro E.A., and Scorza F.A. Analysis of cardiac parameters in animals with epilepsy: possible cause of sudden death?. Arq. Neuropsiquiatr. 63 (2005) 1035-1041
46. Scorza F.A., Colugnati D.B., Pansani A.P., Sonoda E.Y., Arida R.M., and Cavalheiro E.A. Preventing tomorrow's sudden cardiac death in epilepsy today: what should physicians know about this?. Clinics 63 (2008) 389-394
47. Salo L.M., Campos R.R., and McAllen R.M. Differential control of cardiac functions by the brain. Clin. Exp. Pharmacol. Physiol. 33 (2006) 1255-1258
48. Lang D.J., Khorram B., Goghari V.M., Kopala L.C., Vandorpe R.A., Rui Q., Smith G.N., and Honer W.G. Reduced anterior internal capsule and thalamic volumes in first-episode psychosis. Schizophr. Res. 87 (2006) 89-99
49. Nakamura M., Salisbury D.F., Hirayasu Y., Bouix S., Pohl K.M., Yoshida T., Koo M.S., Shenton M.E., and McCarley R.W. Neocortical gray matter volume in first-episode schizophrenia and first-episode affective psychosis: a cross-sectional and longitudinal MRI study. Biol. Psychiatry 62 (2007) 773-783
50. James A.C., James S., Smith D.M., and Javaloyes A. Cerebellar, prefrontal cortex, and thalamic volumes over two time points in adolescent-onset schizophrenia. Am. J. Psychiatry 161 (2004) 1023-1029
51. Seidman L.J., Pantelis C., Keshavan M.S., Faraone S.V., Goldstein J.M., Horton N.J., Makris N., Falkai P., Caviness V.S., and Tsuang M.T. A review and new report of medial temporal lobe dysfunction as a vulnerability indicator for schizophrenia: a magnetic resonance imaging morphometric family study of the parahippocampal gyrus. Schizophr. Bull. 29 (2003) 803-830
52. Brickman A.M., Buchsbaum M.S., Shihabuddin L., Byne W., Newmark R.E., Brand J., Ahmed S., Mitelman S.A., and Hazlett E.A. Thalamus size and outcome in schizophrenia. Schizophr. Res. 71 (2004) 473-484
53. Ohara K. The n-3 polyunsaturated fatty acid/dopamine hypothesis of schizophrenia. Prog. Neuropsychopharmacol. Biol. Psychiatry 31 (2007) 469-474
54. Calon F., and Cole G. Neuroprotective action of omega-3 polyunsaturated fatty acids against neurodegenerative diseases: evidence from animal studies. Prostaglandins Leukot Essent. Fatty Acids 77 (2007) 287-293
55. Ferrari D., Cysneiros R.M., Scorza C.A., Arida R.M., Cavalheiro E.A., Almeida A.C.G., and Scorza F.A. Neuroprotective activity of omega-3 fatty acids against epilepsy-induced hippocampal damage: quantification with immunohistochemical for calcium-binding proteins. Epilepsy Behav. 13 (2008) 36-42
56. Bourre J.M. Roles of unsaturated fatty acids (especially omega-3 fatty acids) in the brain at various ages and during ageing. J. Nutr. Health Aging 8 (2004) 163-174
57. Scorza F.A., Cysneiros R.M., Arida R.M., Terra-Bustamante V.C., de Albuquerque M., and Cavalheiro E.A. The other side of the coin: beneficiary effect of omega-3 fatty acids in sudden unexpected death in epilepsy. Epilepsy Behav. 13 (2008) 279-283
58. Bourre J.M., and Paquotte P. Seafood (wild and farmed) for the elderly: contribution to the dietary intakes of iodine, selenium, DHA and vitamins B12 and D. J. Nutr. Health Aging 12 (2008) 186-192
59. Mazza M., Pomponi M., Janiri L., Bria P., and Mazza S. Omega-3 fatty acids and antioxidants in neurological and psychiatric diseases: an overview. Prog. Neuropsychopharmacol. Biol. Psychiatry 31 (2007) 12-26
60. Lankinen M., Schwab U., Erkkilä A., Seppänen-Laakso T., Hannila M.L., Mussalo H., Lehto S., Uusitupa M., Gylling H., and Oresic M. Fatty fish intake decreases lipids related to inflammation and insulin signaling-a lipidomics approach. PLoS ONE 4 4 (2009) e5258
61. Smith K.M., and Sahyoun N.R. Fish consumption: recommendations versus advisories, can they be reconciled?. Nutr. Rev. 63 (2005) 39-46
62. Jeejeebhoy K.N. Benefits and risks of a fish diet-should we be eating more or less?. Nat. Clin. Pract. Gastroenterol. Hepatol. 5 (2008) 178-179
63. Clarkson T.W., Magos L., and Myers G.J. The toxicology of mercury-current exposures and clinical manifestations. N. Engl. J. Med. 349 (2003) 1731-1737
64. Annonymous. Fish: friend or foe? In addition to heart-healthy omega-3 fats, seafood can carry mercury and other toxins. For most people, the benefits of eating fish far outweigh the risks. Harv. Heart Lett. 17(2007)4-6.
65. US Department of Health and Human Services and US Environmental Protection Agency. FDA and EPA Announce the Revised Consumer Advisory on Methylmercury in Fish. Available at: 〈http://www.cfsan.fda.gov/~dms/admehg3.html〉. accessed January 21, 2009.
66. Domingo J.L. Omega-3 fatty acids and the benefits of fish consumption: is all that glitters gold?. Environ. Int. 33 (2007) 993-998